Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors

Benjamin Theek, Maike Baues, Felix Gremse, Robert Pola, Michal Pechar, Inka Negwer, Kaloian Koynov, Benjamin Weber, Matthias Barz, Willi Jahnen-Dechent, Gert Storm, Fabian Kiessling, Twan Lammers (Corresponding Author)

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
3 Downloads (Pure)

Abstract

Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10–20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.

Original languageEnglish
Pages (from-to)25-34
Number of pages10
JournalJournal of controlled release
Volume282
DOIs
Publication statusPublished - 28 Jul 2018

Fingerprint

Drug Delivery Systems
Blood Vessels
Permeability
Neoplasms
Vascular Tissue Neoplasms
Drug Carriers
Fibrosarcoma
Optical Imaging
Knockout Mice
histidine-rich proteins
Polymers
Macrophages
Pharmaceutical Preparations

Keywords

  • UT-Hybrid-D
  • EPR
  • HRG
  • Nanomedicine
  • pHPMA
  • Tumor targeting
  • Vascular normalization
  • Drug delivery

Cite this

Theek, Benjamin ; Baues, Maike ; Gremse, Felix ; Pola, Robert ; Pechar, Michal ; Negwer, Inka ; Koynov, Kaloian ; Weber, Benjamin ; Barz, Matthias ; Jahnen-Dechent, Willi ; Storm, Gert ; Kiessling, Fabian ; Lammers, Twan. / Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors. In: Journal of controlled release. 2018 ; Vol. 282. pp. 25-34.
@article{6edcb0ee30ad4dd8ba3c95c1e20398fb,
title = "Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors",
abstract = "Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10–20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.",
keywords = "UT-Hybrid-D, EPR, HRG, Nanomedicine, pHPMA, Tumor targeting, Vascular normalization, Drug delivery",
author = "Benjamin Theek and Maike Baues and Felix Gremse and Robert Pola and Michal Pechar and Inka Negwer and Kaloian Koynov and Benjamin Weber and Matthias Barz and Willi Jahnen-Dechent and Gert Storm and Fabian Kiessling and Twan Lammers",
note = "Elsevier deal",
year = "2018",
month = "7",
day = "28",
doi = "10.1016/j.jconrel.2018.05.002",
language = "English",
volume = "282",
pages = "25--34",
journal = "Journal of controlled release",
issn = "0168-3659",
publisher = "Elsevier",

}

Theek, B, Baues, M, Gremse, F, Pola, R, Pechar, M, Negwer, I, Koynov, K, Weber, B, Barz, M, Jahnen-Dechent, W, Storm, G, Kiessling, F & Lammers, T 2018, 'Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors' Journal of controlled release, vol. 282, pp. 25-34. https://doi.org/10.1016/j.jconrel.2018.05.002

Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors. / Theek, Benjamin; Baues, Maike; Gremse, Felix; Pola, Robert; Pechar, Michal; Negwer, Inka; Koynov, Kaloian; Weber, Benjamin; Barz, Matthias; Jahnen-Dechent, Willi; Storm, Gert; Kiessling, Fabian; Lammers, Twan (Corresponding Author).

In: Journal of controlled release, Vol. 282, 28.07.2018, p. 25-34.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors

AU - Theek, Benjamin

AU - Baues, Maike

AU - Gremse, Felix

AU - Pola, Robert

AU - Pechar, Michal

AU - Negwer, Inka

AU - Koynov, Kaloian

AU - Weber, Benjamin

AU - Barz, Matthias

AU - Jahnen-Dechent, Willi

AU - Storm, Gert

AU - Kiessling, Fabian

AU - Lammers, Twan

N1 - Elsevier deal

PY - 2018/7/28

Y1 - 2018/7/28

N2 - Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10–20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.

AB - Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10–20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.

KW - UT-Hybrid-D

KW - EPR

KW - HRG

KW - Nanomedicine

KW - pHPMA

KW - Tumor targeting

KW - Vascular normalization

KW - Drug delivery

UR - http://www.scopus.com/inward/record.url?scp=85047219473&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2018.05.002

DO - 10.1016/j.jconrel.2018.05.002

M3 - Article

VL - 282

SP - 25

EP - 34

JO - Journal of controlled release

JF - Journal of controlled release

SN - 0168-3659

ER -